Tebentafusp-tebn: A Novel Bispecific T-Cell Engager for Metastatic Uveal Melanoma

Uveal melanoma is the most common intraocular cancer in adults. Metastatic uveal melanoma has a poor prognosis. Tebentafusp-tebn is the first drug in the new immune mobilizing monoclonal T-cell receptors against cancer (ImmTAC) class of T cell–directed therapy. Tebentafusp-tebn has been shown in a r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Gwen, Carlson, Daniel, Starr, Jacqueline R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Prescriber's Corner
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514125/
https://www.ncbi.nlm.nih.gov/pubmed/36199496
http://dx.doi.org/10.6004/jadpro.2022.13.7.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514125/
https://www.ncbi.nlm.nih.gov/pubmed/36199496
http://dx.doi.org/10.6004/jadpro.2022.13.7.8

Ejemplares similares